Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
14.08
+0.33 (2.40%)
At close: Mar 11, 2026, 4:00 PM EDT
14.10
+0.02 (0.14%)
Pre-market: Mar 12, 2026, 7:06 AM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 15 analysts that cover Wave Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $31.47, which forecasts a 123.51% increase in the stock price over the next year. The lowest target is $10 and the highest is $52.
Price Target: $31.47 (+123.51%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 8 | 8 | 8 | 7 |
| Buy | 8 | 7 | 8 | 8 | 8 | 8 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 14 | 16 | 16 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $43 → $52 | Strong Buy | Maintains | $43 → $52 | +269.32% | Mar 10, 2026 |
| Wedbush | Wedbush | Buy Maintains $33 → $35 | Buy | Maintains | $33 → $35 | +148.58% | Mar 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +113.07% | Mar 2, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $29 → $27 | Buy | Maintains | $29 → $27 | +91.76% | Feb 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $34 → $41 | Buy | Maintains | $34 → $41 | +191.19% | Feb 5, 2026 |
Financial Forecast
Revenue This Year
38.57M
from 42.73M
Decreased by -9.74%
Revenue Next Year
84.82M
from 38.57M
Increased by 119.93%
EPS This Year
-1.36
from -1.21
EPS Next Year
-1.30
from -1.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 89.3M | 170.4M | |||
| Avg | 38.6M | 84.8M | |||
| Low | n/a | 9.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 108.9% | 341.9% | |||
| Avg | -9.7% | 119.9% | |||
| Low | - | -74.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.14 | -0.23 | |||
| Avg | -1.36 | -1.30 | |||
| Low | -1.66 | -1.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.